RankAlpha logo
Back to Rankings

UFPT

UFPD
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-08-03
View Chart
Current thesis
UFPT remains a differentiated medtech CDMO with about 92% of revenue tied to MedTech, 26 of the top 30 medical OEMs as customers, and visible capacity/program expansion in robotic surgery and safe patient handling; if 2026 ramps convert into better organic growth and margin recovery, the current price can look too low versus the packet’s median target data point.
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-08-04 · AMC.
What can break
CEO transition on June 4, 2026 could create short-term uncertainty even with planned continuity.
Momentum
59
Value
57
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $198.00 · Bull $235.00 · Bear $160.00
Earnings
2026-08-04 · AMC
Data freshness
Prices
As of 2026-08-03
Fundamentals
As of 2026-08-03 • Vendor: Data Vendor v1
Scores
As of 2026-08-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-08-03
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $324.50
Why
Momentum59 · Δ7d +1.7
Value57 · Δ7d -0.7
Sentiment38 · Δ7d -6.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
59
10% active weight
Current posture
7d trendImproving
Δ7d
+1.7
Δ21d
-14.1
Value
57
40% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-1.2
Sentiment
38
49% active weight
Current posture
7d trendSoftening
Δ7d
-6.0
Δ21d
-9.8
Why this grade

Composite grade D. Momentum 59.0 / Value 57.2 / Sentiment 38.1

Fundamentals (TTM)
As of 2026-08-03
Market Cap
$2.07B
Beta
1.10
Shares Out
7.74M
P/E (TTM)
27.6
P/S (TTM)
3.06
P/FCF (TTM)
20.93
Rev YoY
+4.1%
EPS YoY
+1.5%
Gross Margin
+28.4%
Op Margin
+15.6%
Net Debt
$134.18M
Current Ratio
2.91
As of 2026-08-03 • Updated nightlySource: Internal modelMethodology